New test for detecting biomarkers for cancer and diabetes is more than 1000x more detailed and 100% faster than existing methods, new research by the University of Warwick suggests. Developed to undertake a detailed study of collagen, the researchers argue that the same methodology can be used with any protein-based sample and is currently being tested with cancer cells and proteins relevant to Type II diabetes. Named 2D Mass Spectrometry (2DMS), the test provides a new tool in the rapidly expanding field research into the structure and function of proteins, Proteomics. Led by the O'Connor Research Group in the University of Warwick's Department of Chemistry, the researchers found that the large protein collagen can be sliced into smaller fragments and analyzed by multidimensional mass spectrometry to yield data which is 1000x more detailed than previously possible with mass spectrometry, and 100% faster than analyzing the same sample by existing techniques. Commenting on 2DMS and its potential Prof. Peter O'Connor, of the University of Warwick's department of Chemistry and leader of the O’Connor Group, said: "Within each and every cancer cell there are at least a million peptides comprising the protein machines that enable the cell to function.
Why Direct LDL is better than … Calculation???
“'AGECRT' The New Era”
Once upon a time, Conventional Calorimetric Jaffe's test ( discovered on 1886) had assayed creatinine.
Agappe's AGCRP with LEIT is the Gold Standard Inflammation Marker in the Indian IVD…
CRP is one of the most effective early marker of inflammation and infection. CRP is the earliest to measure inflammation because it increases so drastically, for faster Treatment and monitoring. It can signal flare-ups of inflammatory diseases such as rheumatoid arthritis, lupus, and vasculitis.
What makes AGCRP a Gold Standard Product?
“AGA1c – The HbA1c with a difference”
Diabetes is one of the world's major diseases and India ranks among top 3 countries with diabetic population of more than 62 million.
To satisfy the need of the medical community towards the management of diabetes, Agappe introduced AGA1c.
We at Agappe always try to bring innovative products in IVD industry. Mispa count is a revolutionary 3 part + hematology analyser which offers advanced technology solutions to meet the laboratory quality needs. Mispa Count comes with German Technology, having benefits of an entry level 5 part analyser with smaller aperture size for better electrical impedance to get high quality results.
Our Mispa Count is 3 Part differential Hematology Analyzer with 18 parameters and 3 histograms, 10,00,000 sample result storage capacity and through put of 60 samples per hour.